Avery W. Catlin
2016
In 2016, Avery W. Catlin earned a total compensation of $874.7K as Senior Vice President and Chief Financial Officer at Celldex Therapeutics, a 54% decrease compared to previous year.
Compensation breakdown
| Bonus | $105,000 |
|---|---|
| Option Awards | $425,304 |
| Salary | $337,235 |
| Other | $7,132 |
| Total | $874,671 |
Catlin received $425.3K in option awards, accounting for 49% of the total pay in 2016.
Catlin also received $105K in bonus, $337.2K in salary and $7.1K in other compensation.
Rankings
In 2016, Avery W. Catlin's compensation ranked 8,872nd out of 14,075 executives tracked by ExecPay. In other words, Catlin earned more than 37.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,872 out of 14,075 | 37th |
Division Manufacturing | 3,434 out of 5,486 | 37th |
Major group Chemicals And Allied Products | 1,163 out of 1,900 | 39th |
Industry group Drugs | 916 out of 1,543 | 41st |
Industry In Vitro and In Vivo Diagnostic Substances | 27 out of 65 | 59th |
Source: SEC filing on April 28, 2017.
Catlin's colleagues
We found four more compensation records of executives who worked with Avery W. Catlin at Celldex Therapeutics in 2016.
2016
Anthony Marucci
Celldex Therapeutics
Chief Executive Officer
2016
Thomas Davis
Celldex Therapeutics
Chief Medical Officer
2016
Tibor Keler
Celldex Therapeutics
Chief Scientific Officer
2016
Elizabeth Crowley
Celldex Therapeutics